714 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
partners and competitors to the consummation of the transaction and/or potential difficulties in employee retention as a result of the consummation
SC TO-T/A
EX-99
RYZB
RayzeBio Inc.
23 Feb 24
Third party tender offer statement (amended)
7:34am
to the consummation of the proposed transaction and/or potential difficulties in employee retention as a result of the consummation of the proposed transaction
424B5
pj5nn23d
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
lgwme1zwgwql
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T/A
EX-99
w5twtfgtdp2tckb6trv
12 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
876d4h4
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
bctex2m7o 5o7608z
25 Jan 24
Third party tender offer statement
8:13am